Cargando…
Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer
Autores principales: | Xu, Fengrui, Jiang, Zefei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290646/ https://www.ncbi.nlm.nih.gov/pubmed/32566595 http://dx.doi.org/10.21037/atm-2020-21 |
Ejemplares similares
-
Erratum to a right atrium metastasis of breast cancer after long-term endocrine therapy
por: Xu, Fengrui, et al.
Publicado: (2020) -
Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
por: Xu, Fengrui, et al.
Publicado: (2020) -
Erratum to: Bone marrow aspirate concentrate for the treatment of osteochondral lesions of the talus: a systematic review of outcomes
por: Chahla, Jorge, et al.
Publicado: (2016) -
A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin: Erratum
Publicado: (2016) -
Erratum to “Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists”
por: Evaristo-Mendonça, Fabiana, et al.
Publicado: (2020)